Epidemiology of Streptococcus pneumoniae causing acute otitis media among children in Southern Catalonia throughout 2007-2013: Incidence, serotype distribution and vaccine's effectiveness

International Journal of Pediatric Otorhinolaryngology

Volumn 79, Issue 12, 2015, Pages 2104-2108

  Ochoa Gondar, O ^a   Figuerola Massana, E ^b   Vila Corcoles, A ^a   Aguirre, C A ^a   de Diego, C ^a   Satue, E ^a   Gomez, F ^b   Raga, X ^c  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^c Hospital Santa Tecla   (Spain)

Author keywords

Acute otitis media; Children; Effectiveness; Pneumococcal conjugate vaccine; Serotype; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE; VACCINE;

ACUTE OTITIS MEDIA; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CHILD; CHILD HEALTH; COHORT ANALYSIS; DISEASE SURVEILLANCE; DRUG EFFICACY; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PNEUMOCOCCAL INFECTION; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIAE; TREND STUDY; ACUTE DISEASE; CLASSIFICATION; COMPLICATION; HEALTH SURVEY; IMMUNOLOGY; INFANT; MICROBIOLOGY; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD; SEROTYPING; VACCINATION;

ACUTE DISEASE; CHILD; CHILD, PRESCHOOL; FEMALE; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; HUMANS; INCIDENCE; INFANT; MALE; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; POPULATION SURVEILLANCE; PREVALENCE; SEROGROUP; SEROTYPING; SPAIN; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, CONJUGATE;

EID: 84955204476     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2015.09.022     Document Type: Article

References (22)

1. Rovers M.M., Schilder A.G., Zielhuis G.A., Rosenfeld R.M. Otitis media. Lancet 2004, 363:465-473.
2. Kaplan S.L., Center K.J., Barson W.J., Ling-Lin P., Romero J.R., Bradley J.S., et al. Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era. Clin. Infect. Dis. 2015, 60:1339-1345.
3. Hau I., Levy C., Caeymaex L., Cohen R. Impact of pneumococcal conjugate vaccines on microbial epidemiology and clinical outcomes of acute otitis media. Paediatr. Drugs 2014, 16:1-12.
4. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr. Infect. Dis. J. 2000, 19:187-195. The Northern California Kaiser Permanente Vaccine Study Center Group.
5. Fortanier A.C., Venekamp R.P., Boonacker C.W., Hak E., Schilder A.G., Sanders E.A., et al. Pneumococcal conjugate vaccines for preventing otitis media. Cochrane Database Syst. Rev. 2014, 4:CD001480.
6. Centers for Disease Control Prevention Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease, United States, 1998-2003. MMWR Morb. Mortal. Wkly. Rep. 2005, 54:893-897.
7. Singleton R.J., Hennessy T.W., Bulkow L.R., Hammitt L.L., Zulz T., Hurlburt D.A., et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007, 297:1784-1792.
8. Muñoz-Almagro C., Jordan I., Gene A., Latorre C., Garcia-Garcia J.J., Pallares R. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin. Infect. Dis. 2008, 46:174-182.
9. Croxtall J.D., Keating G.M. Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV). Paediatr. Drugs 2009, 11:349-357.
10. Paradiso P.R. Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children. Clin. Infect. Dis. 2011, 52:1241-1247.
11. IDESCAT Web de l'estadística oficial de Catalunya 2015, Available at:, (accessed 20 February 2015). http://www.idescat.cat/.
12. Vila Córcoles A., Ochoa Gondar O., Gutiérrez Pérez A., de Diego Cabanes C., Vila Rovira A., González Lamban B. Evolution of the antipneumococcal vaccination coverage among children in the region of Tarragona, Spain, 2002-2011. Rev. Esp. Salud Publ. 2012, 86:637-643. (in Spanish).
13. Broome C.V., Facklam R.R., Fraser D.W. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N. Engl. J. Med. 1980, 303:549-552.
14. Hanquet G., Kissling E., Fenoll A., George R., Lepoutre A., Lernout T., et al. Pneumococcal serotypes in children in 4 European countries. Emerg. Infect. Dis. 2010, 16:1428-1439.
15. Imöhl M., Reinert R.R., Temporal van der Linden M. Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992-2008). Int. J. Microbiol. 2010, 2010:874189.
16. Muñoz-Almagro C., Ciruela P., Esteva C., Marco F., Navarro M., Bartolome R., et al. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain. J. Infect. 2011, 63:151-162.
17. Martin J.M1, Hoberman A., Paradise J.L., Barbadora K.A., Shaikh N., Bhatnagar S., et al. Emergence of Streptococcus pneumoniae serogroups 15 and 35 in nasopharyngeal cultures from young children with acute otitis media. Pediatr. Infect. Dis. J. 2014, 33:e286-e290.
18. Harboe Z.B., Benfield T.L., Valentiner-Branth P., Hjuler T., Lambertsen L., Kaltoft M., et al. Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin. Infect. Dis. 2010, 50:329-337.
19. Alonso M., Marimon J.M., Ercibengoa M., Pérez-Yarza E.G., Pérez-Trallero E. Dynamics of Streptococcus pneumoniae serotypes causing acute otitis media isolated from children with spontaneous middle-ear drainage over a 12-year period (1999-2010) in a region of northern Spain. PLoS ONE 2013, 8:e54333.
20. Gene A., del Amo E., Iñigo M., Monsonis M., Pallares R., Muñoz-Almagro C. Pneumococcal serotypes causing acute otitis media among children in Barcelona (1992-2011): emergence of the multiresistant clone ST320 of serotype 19 A. Pediatr. Infect. Dis. J. 2013, 32:e128-e133.
21. Marom T., Tan A., Wilkinson G.S., Pierson K.S., Freeman J.L., Chonmaitree T. Trends in otitis media-related health care use in the United States, 2001-2011. JAMA Pediatr. 2014, 168:68-75.
22. Ben-Shimol S., Givon-Lavi N., Leibovitz E., Raiz S., Greenberg D., Dagan R. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV. Clin. Infect. Dis. 2014, 59:1724-1732.